No. Title Date 26 GI Innovation, registering substance patent for immuno-oncology, GI-101A/102, in Europe 2024-03-14 25 Registering patent of combination therapies for GI-101 and GI-102, with blockbuster anti-cancer drugs in U.S. 2023-11-15 24 GI Innovation licenses out allergy treatment to Maruho in Japan 2023-10-17 23 GI Innovation registers U.S. substance patent for immuno-oncology project, GI-101, securing competitive advantages in future commercialization potential 2022-06-27 22 GI Innovation submits a preliminary application for KOSDAQ listing…Unicorn IPO ready to launch 2022-04-21 21 GI Innovation Signs MoU with CellKey for Biomarker Joint Research to Develop Next-generation Innovative Immuno-oncology 2022-03-07 20 GI Innovation·GI Cell·Yonsei University Health System sign MoU to establish a cell therapy center for production of cutting-edge bio pharmaceuticals 2022-03-07 19 GI Innovation Appointing Byung-Geon Rhee, Former CEO of GC Pharma, SCM Lifescience Corp. 2022-03-07 18 GI Innovation, participation in JP Morgan Healthcare Conference 2022-01-10 17 GI Innovation enters into clinical collaboration with AstraZeneca to explore Immuno-oncology GI-101 • Imfinzi® Combination Therapy 2021-12-21 Title Content < 1 2 3 4 >
